How to treat metabolic alkalosis in patients with End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treating Metabolic Alkalosis in ESRD

In ESRD patients with metabolic alkalosis, use conventional hemodialysis with standard bicarbonate dialysate (25-28 mmol/L) to safely and rapidly correct the alkalosis, even in severe cases with pH >7.60 and bicarbonate >55 mmol/L. 1

Pathophysiology in ESRD

  • ESRD patients lose the kidney's primary compensatory mechanism for metabolic alkalosis—the ability to excrete alkaline urine—causing alkaline loads to accumulate rapidly 2, 3
  • Once acid loss (from vomiting or gastric drainage) exceeds metabolic acid production, severe alkalemia develops with compensatory hypoventilation that can cause hypoxia and hypercarbia 2
  • The absence of renal excretory capacity means that even modest ongoing losses can produce extreme alkalosis 3

Treatment Algorithm

Immediate Management

Use conventional hemodialysis with normal bicarbonate dialysate (25-28 mmol/L) as first-line therapy 1

  • This approach has been proven effective and safe for rapid correction of severe metabolic alkalosis in ESRD patients 1
  • Standard bicarbonate dialysis successfully corrects acid-base homeostasis without requiring specialized low-bicarbonate or acidic dialysate 2, 1
  • Hydration and achieving normal central venous pressure alone will not correct the alkalosis in oliguric ESRD patients 1

For Extreme Cases (pH >7.60, HCO₃ >55 mmol/L)

Consider continuous renal replacement therapy (CRRT) when rapid correction poses risk of dialysis disequilibrium 4

  • Use sustained low-efficiency dialysis (SLED) with blood flow 60 ml/min and dialysate flow 400 ml/min to achieve gradual correction over 24-26 hours 4
  • CRRT allows controlled bicarbonate removal using single-pool kinetic modeling to predict and regulate systemic bicarbonate levels 4
  • This approach mitigates pronounced decreases in plasma osmolality, particularly important in patients with concurrent hypernatremia 4

Dialysate Composition

Use either lactate or bicarbonate buffer in the dialysate for most ESRD patients 5

  • Standard bicarbonate dialysate concentrations (25-28 mmol/L) are appropriate and effective 1
  • Both lactate and bicarbonate can correct metabolic acidosis, but bicarbonate is preferred in patients with liver failure or lactic acidosis 5

Prevention Strategies

Implement prophylactic acid suppression in at-risk patients 1

  • H₂ blockers or proton pump inhibitors have demonstrated prophylactic effect against metabolic alkalosis formation in ESRD patients with vomiting or gastric drainage 1
  • This is particularly important given that ESRD patients cannot compensate through renal mechanisms 3

Critical Monitoring

  • Monitor arterial blood gases to assess both alkalemia severity and degree of compensatory hypoventilation 2
  • Check for hypoxia and hypercarbia resulting from respiratory compensation 2
  • Assess mental status changes (stupor, seizures) which indicate severe alkalemia requiring urgent intervention 1

Common Pitfalls

Avoid regional citrate anticoagulation during dialysis in patients with pre-existing alkalosis 6

  • Regional citrate dialysis delivers several hundred mEq of potential bicarbonate and can cause or worsen severe metabolic alkalosis 6
  • This is particularly problematic with repeated treatments 6

Do not rely on fluid resuscitation alone 1

  • Unlike metabolic alkalosis in patients with intact renal function, hydration will not correct the disorder in oliguric ESRD patients 1
  • Dialysis is required to remove the excess bicarbonate 1, 3

References

Research

Extreme metabolic alkalosis treated with normal bicarbonate hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2001

Research

Severe metabolic alkalosis in a hemodialysis patient.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2011

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.